Urge your US House of Representatives member to support increasing the National Institutes of Health’s headache research funding by sending this pre-written e-mail no later than Monday, March 17. That’s all that’s required, though you are encouraged to include a personal note on how headache disorders affect you.
According to the National Headache Foundation, “NIH grants for migraine total approximately $13M per year, representing less than .05% of the total NIH budget. Very little headache research apart from migraine is funded and the NIH has no institute, center, or study section wholly devoted to pain, let alone headache disorders.”
This letter from the Alliance for Headache Disorders Advocacy has details on the initiative:
AHDA Congressional Action Alert: Increase NIH funding for Headache Research
Dear AHDA advocates –
Well, the key moment has arrived for you to contact your Member of the US House of Representatives to take action for increasing NIH research for headache disorders.
A Dear Colleague letter was sent Monday, March 10, by Representatives Peter Welch and James Moran to all House offices, urging all Members of the House to co-sign a letter to Representatives David Obey and James Walsh. The Obey/Walsh letter requests inclusion of language that supports headache research to be appended to the FY09 appropriations bill for NIH. (For details, see the AHDA homepage.)
The more Representatives that co-sign the Obey/Walsh letter, the greater are the chances that the language will be included. The Obey/Walsh letter must be submitted with signatures by 3/19. This unfortunate deadline was a late-breaking surprise for us, so we have little more than a week to get as many signatures as possible. Please use the space below to compose your message to your Representative and urge her/him to co-sign the Obey/Walsh letter now.
We are also working on a Senate Dear Colleague letter right now and we will let you know when the time is right for you to contact your Senators too.
Through collective advocacy we will improve the care for individuals with headache disorders. Thanks very much for your help.
Best regards to you all,
Robert Shapiro, MD, PhD; Burlington, Vermont
William Young, MD; Philadelphia, Pennsylvania
Brad Klein, MD, MBA; Philadelphia, Pennsylvania
Teri Robert, PhD; Washington, West Virginia